NATCO Pharma informs about credit rating

29 Nov 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), NATCO Pharma has informed that ICRA vide their letter No. ICRA/Natco Pharma Limited/28112025/2 dated November 28, 2025 has reaffirmed/assigned the credit ratings of the Company, which are enclosed. Copy of aforesaid letter issued by ICRA Limited is also enclosed as Annexure.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×